Schedule of Changes in Contract Assets and Contract Liabilities |
The following table summarizes the changes in the contract asset and liability balances for the six months ended June 30, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Dollars in thousands | | | | | Total | | | | Contract Asset | | | | | | | | | Contract asset, January 1, 2025 | | | | | $ | 6,146 | | | | | Transferred to trade receivables from contract asset included in beginning of the year contract asset | | | | | $ | (6,146) | | | | | | | | | | | | | | Contract asset, net of transferred to trade receivables on contracts during the period | | | | | $ | 3,491 | | | | | Contract asset, June 30, 2025 | | | | | $ | 3,491 | | | | | | | | | | | | | | Contract Liability | | | | | | | | | Contract liability, January 1, 2025 | | | | | $ | 19,669 | | | | | Recognition of revenue included in beginning of year contract liability | | | | | $ | (6,573) | | | | | | | | | | | | | | Contract liability, net of revenue recognized on contracts during the period | | | | | $ | 8,828 | | | | | Foreign currency translation | | | | | $ | 132 | | | | | Contract liability, June 30, 2025 | | | | | $ | 22,056 | | | | |
|
Schedule of Disaggregation of Revenue |
The following table presents revenues disaggregated by the major sources of revenues for the three and six months ended June 30, 2025 and 2024 (dollar amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | Three Months Ended June 30, 2024 | | Six Months Ended June 30, 2025 | | Six Months Ended June 30, 2024 | Neurosurgery | $ | 208,992 | | | $ | 205,502 | | | $ | 399,904 | | | $ | 407,770 | | Instruments | 53,080 | | | 54,537 | | | 104,030 | | | 98,910 | | ENT | 41,886 | | | 41,722 | | | 80,688 | | | 51,515 | | Total Codman Specialty Surgical | 303,958 | | | 301,761 | | | 584,622 | | | 558,195 | | | | | | | | | | Wound Reconstruction and Care | 84,747 | | | 87,695 | | | 159,526 | | | 168,572 | | Private Label | 26,900 | | | 28,719 | | | 54,110 | | | 60,280 | | Total Tissue Technologies | 111,647 | | | 116,414 | | | 213,636 | | | 228,852 | | Total revenue | $ | 415,605 | | | $ | 418,175 | | | $ | 798,258 | | | $ | 787,047 | | .
|